BeStock  

10x Genomics TXG

US equityMarket cap rank #1749AI medical concept stocks
$51.80 −$5.58 (-9.72%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $51.01 -1.53%
Open$55.77
Prev close$57.38
Day range$51.30 – $56.44
Volume3.23M
Market cap$6.81B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±5.6%last 16 reports
Closed higher11 of 1669% of the time
Best reaction+17.3%
Worst reaction-8.1%

Stock move on the day after each report

+0.8%2023/Q4-8.1%2024/Q1+4.5%2024/Q2+4.4%2024/Q3-0.5%2024/Q4+1.6%2025/Q1-4.0%2025/Q2+17.3%2025/Q3+3.5%2025/Q4-3.7%2026/Q1+14.1%2026/Q2+2.1%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Nov 2026After Market±18.6%+2.10%Within range
2026/Q26 Aug 2026After Market±13.7%+14.10%Bigger than priced
2026/Q17 May 2026After Market±13.2%-3.66%Within range
2025/Q412 Feb 2026After Market±16.0%+3.48%Within range
2025/Q36 Nov 2025After Market±21.6%+17.31%Within range
2025/Q27 Aug 2025After Market±21.0%-3.98%Within range
2025/Q18 May 2025After Market±30.3%+1.62%Within range
2024/Q412 Feb 2025After Market±18.8%-0.50%Within range
2024/Q329 Oct 2024After Market±20.3%+4.43%Within range
2024/Q28 Aug 2024After Market±15.9%+4.50%Within range
2024/Q130 Apr 2024After Market±17.3%-8.06%Within range
2023/Q415 Feb 2024After Market±17.1%+0.79%Within range
2023/Q32 Nov 2023After Market±15.1%+8.73%Within range
2023/Q23 Aug 2023After Market±13.4%-4.19%Within range
2023/Q13 May 2023After Market±14.6%+1.30%Within range
2022/Q415 Feb 2023After Market±13.1%+11.15%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$150.67M+1.1% YoY
Operating profit-$16.06M+50.2% YoY
Net profit-$19.43M+29.3% YoY
Diluted EPS-$0.15+31.8% YoY
Free cash flow$14.86M-65.1% YoY
Operating cash flow$15.83M

Revenue, last 8 quarters

$165.0MDec '24$154.9MMar '25$172.9MJun '25$149.0MSep '25$166.0MDec '25$150.8MMar '26$151.0MJun '26$150.7MSep '26

Net profit, last 8 quarters

$-49.0MDec '24$-34.4MMar '25$34.5MJun '25$-27.5MSep '25$-16.3MDec '25$-13.5MMar '26$-17.9MJun '26$-19.4MSep '26

Profitability & balance sheet

Gross margin71.9%
Operating margin-12.2%
Net margin-10.8%
Return on equity-8.3%
Return on assets-6.4%
Return on invested capital-9.0%
Current ratio5.12
Liabilities / assets21.2%
Cash & investments$575.68M
Total debt$63.85M
Net cash (debt)$511.83M
Free cash flow / sales15.2%

Discussion

No comments yet — be the first to weigh in on TXG.

Sign in to join the discussion.

Scroll to Top